Purpose To review and update the incidence and risk factors for breast cancer-related
lymphedema based on cohort studies. Methods The study was guided by the Joanna Briggs …

Lymphedema is a chronic, progressive disease that affects approximately 140 to 200 million
people worldwide. 1, 2 There is no curative treatment and palliation is challenging. The …

Importance Breast cancer–related lymphedema (BCRL) is a common complication of
axillary lymph node dissection (ALND) but can also develop after sentinel lymph node …

背景乳腺癌相关淋巴水肿(BCRL) 是乳腺癌术后最主要的并发症, 目前临床尚无有效的治疗手段.
因此, 及早识别其发生的危险因素具有重要意义, 但现有研究结论尚存争议, 且国内尚无相关系统 …

Purpose To review and critically evaluate currently available risk prediction models for
breast cancer-related lymphedema (BCRL). Methods PubMed, Embase, CINAHL, Scopus …

Objective We aimed to establish a scoring system to predict the risk of breast cancer-related
lymphedema. Methods From April 2017 to December 2018, 533 patients who previously …

Purpose We previously constructed a nomogram for predicting the risk of arm lymphedema
following contemporary breast cancer treatment. This nomogram should be validated in …

Purpose We aimed to evaluate whether neoadjuvant chemotherapy (NAC) could be a risk
factor for breast cancer-related lymphedema (BCRL) associated with axillary lymph node …

The physical and psychological side effects of breast cancer therapies can have substantial
impact on survivors' physical and social functioning. Roughly half of the more than 3 million …

Objective To use machine learning algorithms to predict the death outcomes of patients with
triple-negative breast cancer, 5 years after discharge. Methods 1570 stage I-III breast cancer …